Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy

Muscle and Nerve

Volumn 38, Issue 5, 2008, Pages 1447-1454

  Yiannikas, Con ^a   Vucic, Steve ^b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chronic demyelinating neuropathy; Somatosensory evoked potentials

Indexed keywords

MYELIN ASSOCIATED GLYCOPROTEIN; PROTEIN ANTIBODY;

ADULT; AGED; ARTICLE; ATAXIA; CHRONIC ACQUIRED DEMYELINATING POLYNEUROPATHY; CHRONIC DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; DEMYELINATING NEUROPATHY; DEMYELINATION; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; MALE; MEDIAN NERVE; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; NERVE CONDUCTION; NERVE POTENTIAL; PERIPHERAL NERVE; POLYNEUROPATHY; PRIORITY JOURNAL; SENSORY NERVE; TIBIAL NERVE;

ADULT; AGED; AGED, 80 AND OVER; ELECTRIC STIMULATION; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMANS; MALE; MEDIAN NERVE; MIDDLE AGED; NEURAL CONDUCTION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; REACTION TIME; SURAL NERVE;

EID: 55749104672     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21078     Document Type: Article

References (26)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991:617-618.
2. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-884.
3. Berger AR, Busis NA, Logigian EL, Wierzbicka M, Shahani BT. Cervical root stimulation in the diagnosis of radiculopathy. Neurology 1987;37:329-332.
4. Brown W, Feasby T. Sensory evoked potentials in Guillain-Barre polyneuropathy. J Neurol Neurosurg Psychiatry 1984;47:288-291.
5. Busby M, Donaghy M. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. J Neurol 2003;250:714-724.
6. Cosi V, Poloni M, Mazzini L, Callieco R. Somatosensory evoked potentials in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1984;47:857-861.
7. Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201.
8. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994;117:941-947.
9. Katz JS, Wolfe GI, Bryan WW, Jackson CE, Amato AA, Barohn RJ. Electrophysiologic findings in multifocal motor neuropathy. Neurology 1997;48:700-707.
10. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology 2000;54:615-620.
11. Katz JS, Saperstein DS. Asymmetric acquired demyelinating polyneuropathies: MMN and MADSAM. Curr Treat Options Neurol 2001;3:119-125.
12. Matsumoto A, Kawashima A, Doi S, Moriwaka F, Tashiro K. [The spinal somatosensory evoked potentials in amyotrophic lateral sclerosis in relation to the spinal cord conduction velocities.] No To Shinkei 1999;51:41-47.
13. Nicolas G, Maisonobe T, Le Forestier N, Leger JM, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;25:26-30.
14. Ohkoshi N, Harada K, Nagata H, Yato M, Shoji S. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves. Eur Neurol 2001;45:241-248.
15. Olney RK, Lewis RA, Putnam TD, Campellone JV Jr. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003;27:117-121.
16. Parry GJ, Aminoff MJ. Somatosensory evoked potentials in chronic acquired demyelinating peripheral neuropathy. Neurology 1987;37:313-316.
17. Ropper AH, Chiappa KH. Evoked potentials in Guillain-Barre syndrome. Neurology 1986;36:587-590.
18. Rotta FT, Sussman AT, Bradley WG, Ram Ayyar D, Sharma KR, Shebert RT. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2000;173:129-139.
19. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999;22:560-566.
20. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311-324.
21. Sinnreich M, Klein CJ, Daube JR, Engelstad J, Spinner RJ, Dyck PJ. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology 2004;63:1662-1669.
22. Subramaniam JS, Yiannikas C. Multimodality evoked potentials in motor neuron disease. Arch Neurol 1990;47:989-994.
23. Trojaborg W, Hays AP, van den Berg L, Younger DS, Latov N. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 1995;18:730-735.
24. Vajsar J, Taylor MJ, MacMillan LJ, Murphy EG, Logan WJ. Somatosensory evoked potentials and nerve conduction studies in patients with Guillain-Barre syndrome. Brain Dev 1992;14:315-318.
25. Vucic S, Black K, Siao Tick Chong P, Cros D. Cervical nerve root stimulation. Part II. Findings in primary demyelinating neuropathies and motor neuron disease. Clin Neurophysiol 2006;117:398-404.
26. Walsh JC, Yiannikas C, McLeod JG. Abnormalities of proximal conduction in acute idiopathic polyneuritis: comparison of short latency evoked potentials and F-waves. J Neurol Neurosurg Psychiatry 1984;47:197-200.